China Pharma Holdings Inc. (AMEX:CPHI) saw an upside of 8.31% to close Tuesday at $0.12 after adding $0.01 on the day. The 5-day average trading volume is 1,813,260 shares of the company’s common stock. It has gained $0.1160 in the past week and touched a new high 2 times within the past 5 days. An average of 1,720,205 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 2,976,756.
CPHI’s 1-month performance is -1.61% or -$0.0007 on its low of $0.0800 reached on 01/03/23. The company’s shares have touched a 52-week low of $0.08 and high of $0.53, with the stock’s rally to the 52-week high happening on 01/12/23. YTD, CPHI has achieved 20.96% or $0.0201 and has reached a new high 4 times. However, the current price is down -77.95% from the 52-week high price.
CPHI stock has a beta of 0.46. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.70 while the price-to-book (PB) in the most recent quarter is 1.93.
China Pharma Holdings Inc.’s quick ratio for the period ended September 29 was 0.20, with the current ratio over the same period at 0.40.. In terms of profitability, the gross margin trailing 12 months is -2.90%. The firm’s gross profit as reported stood at $0.35 million against revenue of $9.64 million.
For the quarterly period ending September 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -5.06% to -$0.79 million, while revenue of -$0.89 million was -12.66% off the previous quarter. Analysts expected CPHI to announce $0.12 per share in earnings in its latest quarter, but it posted $0.08, representing a -33.30% surprise. EBITDA for the quarter stood at more than $24000.0. CPHI stock balance sheet for the quarter ending September 29 shows that total liabilities totaled 13.37 million, with total debt at $10.11 million. Shareholders hold equity totaling $51.64 million.
Let’s look briefly at China Pharma Holdings Inc. (CPHI) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 24 January was 58.07% to suggest the stock is trending Neutral, with historical volatility in this time period at 77.01%.
The stock’s 5-day moving average is $0.1077, reflecting a +7.01% or $0.0076 change from its current price. CPHI is currently trading -1.69% above its 20-day SMA, -39.33% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +9.02% and SMA200 by-68.73%.
Stochastic %K and %D was 73.77% and 65.91% and the average true range (ATR) pointed at 0.0122. The RSI (14) points at 53.80%, while the 14-day stochastic is at 85.64% with the period’s ATR at 0.0138. The stock’s 9-day MACD Oscillator is pointing at 0.0006 and 0.0030 on the 14-day charts.
In the most recent analyst report for China Pharma Holdings Inc. (AMEX: CPHI), Rodman & Renshaw launched coverage with a Mkt outperform rating. Analysts offering their rating for CPHI stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate CPHI as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 1 have offered a “buy” rating.
What is CPHI’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $4.50 and a high of $4.50, with their median price target at $4.50. Looking at these predictions, the average price target given by analysts is for China Pharma Holdings Inc. (CPHI) stock is $4.50.